Treatment Registry

Company

RestorLife Med

RestorLife Med publishes compounded semaglutide and compounded tirzepatide, from $56 to $99 a month. The lowest requires a 3-month plan.

  • 2 programs
  • 2 molecules
  • 2 readings

Read from restorlifemed.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.

Go to RestorLife Med

Visit RestorLife Med

We earn nothing from this link. RestorLife Med has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

What it costs

first month, including the required fees on record · $168 charged today · GLP-1 Microdose, 3 month (list $113/mo)

first month, including the required fees on record · $297 charged today · Dual GIP/GLP-1 Microdose, 3 month (list $133/mo)

Terms

StatesAll 50 states

Not yet checked: pharmacy, membership and consultation fee.

Terms can differ between this company’s programs; each entry carries its own.

Programs

EntryProviderPer month
at its shortest term		Link
TR-0489RestorLife Med$56
GLP-1 Microdose, 3 month (list $113/mo)		Record
TR-0490RestorLife Med$99
Dual GIP/GLP-1 Microdose, 3 month (list $133/mo)		Record

Notes

Recorded against this company rather than one program.

September 2, 2026

  1. 1. Prices are for a first-order-discounted rate shown beside a crossed-out list price (e.g. '$149 $219/mo'); both numbers were captured, with perMonth set to the actual advertised price and the list price kept in each quote. In addition to the standard-dose semaglutide/tirzepatide protocols, the site sells 'microdose' tiers of each drug at lower doses/prices, recorded as separate price entries under the same drug. The homepage names the physician as 'Licensed in all 50 states,' but that describes the physician's individual licensure, not a company-wide service-area claim — the site's own Terms of Service instead says only 'certain states' are served with no list, so states was recorded as not-found rather than all-50. RestorLife Med's telemedicine consent is issued by 'Beluga Health, P.A.' — the same Beluga Health checked separately in this batch as a B2B infrastructure vendor.

Before you act

Cite this

Treatment Registry. (2026). RestorLife Med: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/restorlife-med